{"entity":{"type":"insider","cik":"0001608901","url":"/insider/0001608901","json_url":"/insider/0001608901.json","name":"Fiorino Anthony S.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":6,"first":"2014-09-16","last":"2020-02-04","span_basis":"filed_date"},"name_variants":[{"name":"Fiorino Anthony S.","source":"filing","n_filings":6,"first_seen":"2014-09-16","last_seen":"2020-02-04"}],"transactions":[{"id":2157845,"accession":"0001608901-20-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001608901-20-000002","line_url":"/filing/0001608901-20-000002#line-1","is_derivative":false,"issuer_cik":"0001208261","issuer_name":"IMMUNE PHARMACEUTICALS INC","issuer_ticker":"IMNPQ","issuer_name_source":null,"issuer_url":"/issuer/0001208261","owner_cik":"0001608901","owner_name":"Fiorino Anthony S.","owner_url":"/insider/0001608901","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":0.0035,"price_display":"0.00","price_state":"stated","total_value":262.5,"total_display":"262.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-04","scope":"insider"},{"id":6066928,"accession":"0001144204-18-030469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-030469","line_url":"/filing/0001144204-18-030469#line-1","is_derivative":false,"issuer_cik":"0001208261","issuer_name":"IMMUNE PHARMACEUTICALS INC","issuer_ticker":"IMNP","issuer_name_source":null,"issuer_url":"/issuer/0001208261","owner_cik":"0001608901","owner_name":"Fiorino Anthony S.","owner_url":"/insider/0001608901","role":"Officer (Chief Medical Officer and COO)","officer_title":"Chief Medical Officer and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.2391,"price_display":"0.24","price_state":"stated","total_value":5977.5,"total_display":"5,977.50","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-22","filed_date":"2018-05-23","scope":"insider"},{"id":6036431,"accession":"0001144204-18-029798","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-029798","line_url":"/filing/0001144204-18-029798#line-1","is_derivative":false,"issuer_cik":"0001208261","issuer_name":"IMMUNE PHARMACEUTICALS INC","issuer_ticker":"IMNP","issuer_name_source":null,"issuer_url":"/issuer/0001208261","owner_cik":"0001608901","owner_name":"Fiorino Anthony S.","owner_url":"/insider/0001608901","role":"Officer (Chief Medical Officer and COO)","officer_title":"Chief Medical Officer and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.258,"price_display":"0.26","price_state":"stated","total_value":12900.0,"total_display":"12,900.00","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-17","filed_date":"2018-05-18","scope":"insider"},{"id":6546664,"accession":"0001144204-14-061373","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-061373","line_url":"/filing/0001144204-14-061373#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001608901","owner_name":"Fiorino Anthony S.","owner_url":"/insider/0001608901","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":3.599,"price_display":"3.60","price_state":"stated","total_value":1079.7,"total_display":"1,079.70","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-15","filed_date":"2014-10-15","scope":"insider"},{"id":6546660,"accession":"0001144204-14-061373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-061373","line_url":"/filing/0001144204-14-061373#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001608901","owner_name":"Fiorino Anthony S.","owner_url":"/insider/0001608901","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":3.59,"price_display":"3.59","price_state":"stated","total_value":718.0,"total_display":"718.00","shares_owned_after":2200.0,"shares_owned_after_display":"2,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-15","filed_date":"2014-10-15","scope":"insider"},{"id":6282393,"accession":"0001144204-14-056992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-056992","line_url":"/filing/0001144204-14-056992#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001608901","owner_name":"Fiorino Anthony S.","owner_url":"/insider/0001608901","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":3.84,"price_display":"3.84","price_state":"stated","total_value":3072.0,"total_display":"3,072.00","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-18","filed_date":"2014-09-19","scope":"insider"},{"id":6349147,"accession":"0001144204-14-056082","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-14-056082","line_url":"/filing/0001144204-14-056082#line-4","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001608901","owner_name":"Fiorino Anthony S.","owner_url":"/insider/0001608901","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.2875,"price_display":"0.29","price_state":"stated","total_value":1437.5,"total_display":"1,437.50","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-09-16","scope":"insider"},{"id":6349143,"accession":"0001144204-14-056082","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-14-056082","line_url":"/filing/0001144204-14-056082#line-3","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001608901","owner_name":"Fiorino Anthony S.","owner_url":"/insider/0001608901","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":0.2835,"price_display":"0.28","price_state":"stated","total_value":850.5,"total_display":"850.50","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-09-16","scope":"insider"},{"id":6349136,"accession":"0001144204-14-056082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-14-056082","line_url":"/filing/0001144204-14-056082#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001608901","owner_name":"Fiorino Anthony S.","owner_url":"/insider/0001608901","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.285,"price_display":"0.28","price_state":"stated","total_value":2137.5,"total_display":"2,137.50","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-12","filed_date":"2014-09-16","scope":"insider"},{"id":6349131,"accession":"0001144204-14-056082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-056082","line_url":"/filing/0001144204-14-056082#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001608901","owner_name":"Fiorino Anthony S.","owner_url":"/insider/0001608901","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":700.0,"total_display":"700.00","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-12","filed_date":"2014-09-16","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001208261","name":"IMMUNE PHARMACEUTICALS INC","url":"/issuer/0001208261","role":"Director, Officer (Chief Medical Officer and COO)","n_filings":3,"first_seen":"2018-05-18","last_seen":"2020-02-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001137883","name":"BRAINSTORM CELL THERAPEUTICS INC.","url":"/issuer/0001137883","role":"Officer (Chief Executive Officer)","n_filings":3,"first_seen":"2014-09-16","last_seen":"2014-10-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001608901","retrieved_at":"2026-08-21T23:15:34+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}